-

Nomi Health Adds Access to Novavax COVID Vaccine in Utah

Novavax, in addition to Moderna, Pfizer and Johnson & Johnson vaccines, now available at West Valley location

OREM, Utah--(BUSINESS WIRE)--Nomi Health, a direct healthcare company dedicated to improving access and lowering costs in the healthcare system, has expanded its COVID vaccine services with the addition of the Novavax vaccine, now available at the West Valley Nomi Health location. In addition to Novavax, this location also distributes Pfizer, Moderna and Johnson & Johnson vaccines.

All vaccines distributed by Nomi Health are free. Insurance information is not required but will be requested upon service.

Location and hours of operation:

  • West Valley City - Centennial Park, 5405 W 3100 S West Valley City UT 84119
    • COVID vaccines are available Thursday - Saturday 9am - 6pm MT:
      • Ages 6 months - 4 years old: Pfizer
      • Ages 6 months - 5 years old: Moderna
      • Ages 5 years old - 17 years old: Pfizer + boosters
      • Adult 18 years old+: Moderna, Pfizer, Novavax, Johnson & Johnson + boosters

To continue to provide the fastest, most reliable and affordable services, Nomi Health’s vaccines are available free of cost, but Nomi’s staff is requesting insurance card information, when available.

No appointment is required, and all locations are first come, first served, but registration is encouraged to ensure the fastest services, Nomi Vaccine Program (nomihealth.com).

For general customer service, please call (801) 783-1665.

About Nomi Health

Nomi Health is a direct healthcare company delivering easy-to-access, low-cost care across the U.S., to the benefit of patients, providers and the buyers of healthcare in both the public and private sectors. Nomi Health is based in Orem, Utah and is composed of a team of more than 3,000 professionals nationwide, actively working to lower healthcare costs, widen care access and improve the overall patient experience. The company’s Nomi Care platform -- featuring local clinical and operations field teams, a sustainable supply chain, and seven networked laboratories - has served more than 11 million Americans with everyday healthcare services since its inception in 2019. Nomi Connect is a business operating system and payment platform enabling organizations to purchase healthcare directly and providers to be reimbursed in real time. Nomi Health is led by an experienced, cross-functional leadership team with clinical, healthcare, technology and finance backgrounds. Visit us on social media @NomiHealth and www.nomihealth.com.

Contacts

Jenny Olson
jenny@mpublicrelations.com
310-773-2568

Nomi Health


Release Versions

Contacts

Jenny Olson
jenny@mpublicrelations.com
310-773-2568

More News From Nomi Health

CerpassRx Launches AI Engine Powered By Waltz Health to Deliver Real-Time Savings and Spend Management for Specialty Drugs

DALLAS & CHICAGO--(BUSINESS WIRE)--CerpassRx, a leader in pharmacy benefit management (PBM), today announced the launch of the Intelligent Specialty Engine, an AI-enabled platform powered by Waltz Health to manage specialty drug spend. CerpassRx’s innovative approach includes real-time analytics and specialty spend management capabilities that drive significant cost savings, improve transparency and optimize the specialty drug experience for health plan customers and their members – or self-ins...

CareSource and Nomi Health Launch Innovative Partnership to Improve Healthcare Access and Outcomes

DAYTON, Ohio--(BUSINESS WIRE)--CareSource, a non-profit health plan with over 2 million members, has selected Nomi Health to partner with it in launching a new comprehensive effort to help close gaps in healthcare access and outcomes for its Medicaid members across Ohio, Georgia, and Indiana. This collaboration aims to enhance access to essential healthcare services and improve overall health outcomes for people facing barriers to care. "This partnership with Nomi Health represents a significan...

Weight Loss Drugs Weigh Heavy on Employer Health Plans

OREM, Utah--(BUSINESS WIRE)--A meteoric rise in the popularity of glucagon-like peptide-1 (GLP-1) medications such as Ozempic, Wegovy and Mounjaro is creating financial challenges for employer-sponsored health plans. New data from Nomi Health, a company changing healthcare economics, reveals that spending on these diabetes and weight loss drugs went up 253% from 2020 to 2023, surpassing $1 billion last year and making up nearly 10% of total prescription costs for employers. Nomi Health analyzed...
Back to Newsroom